$2.36
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Protalix BioTherapeutics Earnings Estimates, EPS & Revenue | AMEX:PLX | Benzinga
Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 17
EPS
$0.090
Quarterly Revenue
$18.22M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$53.40M
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics | -$0.06 | — | — | — | $3.75M | — | — | — | 05/09/2025 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.07 | $0.07 | $0.09 | 28.57% | $10.49M | $18.76M | $18.22M | -2.89% | 03/17/2025 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.04 | $0.06 | $0.03 | -50.00% | $10.35M | $16.26M | $17.96M | 10.45% | 11/14/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.21 | $0.02 | -$0.03 | -250.00% | $35.08M | $12.50M | $13.47M | 7.79% | 08/14/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.05 | -$0.02 | -$0.06 | -200.00% | $9.59M | $9.20M | $3.75M | -59.26% | 05/10/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.07 | -$0.03 | -$0.07 | -133.33% | $8.62M | $5.80M | $10.49M | 80.79% | 03/14/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.07 | -$0.04 | -$0.04 | 0.00% | $14.18M | $10.00M | $10.35M | 3.45% | 11/06/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.11 | -$0.04 | $0.21 | 625.00% | $8.75M | $10.22M | $35.08M | 243.20% | 08/07/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.05 | — | -$0.05 | — | $16.09M | — | $9.59M | — | 05/04/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.15 | -$0.07 | 53.33% | $8.55M | $6.12M | $8.62M | 40.80% | 02/27/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.09 | -$0.15 | -$0.07 | 53.33% | $12.05M | $14.18M | $14.18M | 0.00% | 11/14/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.25 | -$0.18 | -$0.11 | 38.89% | $6.43M | — | $8.75M | — | 08/15/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.05 | -$0.05 | 0.00% | $11.32M | $15.50M | $16.09M | 3.77% | 05/16/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.03 | -$0.11 | -$0.14 | -27.27% | $19.50M | $7.79M | $8.55M | 9.74% | 03/31/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.11 | -$0.09 | 18.18% | $10.79M | $7.79M | $12.05M | 54.74% | 11/15/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.13 | -$0.08 | -$0.25 | -212.50% | $10.97M | $8.30M | $6.43M | -22.57% | 08/16/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.10 | -$0.17 | -$0.14 | 17.65% | $21.65M | $10.95M | $11.32M | 3.38% | 05/14/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.02 | -$0.08 | $0.03 | 137.50% | $3.78M | $11.99M | $19.50M | 62.59% | 03/30/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.20 | -$0.17 | -$0.14 | 17.65% | $14.25M | $10.08M | $10.79M | 7.04% | 10/29/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.50 | -$0.20 | -$0.13 | 35.00% | $12.25M | $10.87M | $10.97M | 0.89% | 08/10/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.50 | -$0.30 | $0.10 | 133.33% | $10.44M | $6.60M | $21.65M | 227.97% | 06/01/2020 | Get Alert |
Protalix BioTherapeutics (PLX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-17 | $0.09 | $0.07 | 28.6 % |
| Q3 | 2024-11-14 | $0.03 | $0.06 | -50.0 % |
| Q2 | 2024-08-14 | $-0.03 | $0.02 | -250.0 % |
| Q1 | 2024-05-10 | $-0.06 | $-0.02 | -200.0 % |
Protalix BioTherapeutics (PLX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-17 | $18.22M | $18.76M | -2.89 % |
| Q3 | 2024-11-14 | $17.96M | $16.26M | 10.4 % |
| Q2 | 2024-08-14 | $13.47M | $12.50M | 7.79 % |
| Q1 | 2024-05-10 | $3.75M | $9.20M | -59.3 % |
FAQ
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics (PLX) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on March 17, 2025 for Q4.
What were the latest earnings per share (EPS) for Protalix BioTherapeutics (AMEX:PLX)?
The Actual EPS was $0.09, which beat the estimate of $0.07.
What were Protalix BioTherapeutics’s (AMEX:PLX) revenues?
The Actual Revenue was $18.2M, which missed the estimate of $18.8M.
Browse earnings estimates, EPS, and revenue on all stocks.